Short-term effects of population-based screening for prostate cancer on health-related quality of life

Journal of the National Cancer Institute

Volumn 90, Issue 12, 1998, Pages 925-931

  Essink Bot, Marie Louise ^a   De Koning, Harry J ^a   Nijs, Hubert G T ^a,b,d   Kirkels, Wim J ^c   Van Der Maas, Paul J ^a   Schröder, Fritz H ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Public Health Service of the Rotterdam Region   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Munic Hlth Serv Zuid Holland Zuid   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EUROPE; FINGER; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTICENTER STUDY; NETHERLANDS; PHYSICAL EXAMINATION; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECTUM; SELF EVALUATION; UNITED STATES;

EID: 0032540698     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.12.925     Document Type: Article

References (21)

1. Schroder FH, Denis LJ, Kirkels W, De Koning HJ, Standaert B. European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies. Cancer 1995;76:129-34.
2. Auvinen A. Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland. Br J Cancer 1996;74:568-72.
3. Kramer BS, Gohagan J, Prorok PC, Smart C. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 1993;71:589-93.
4. Auvinen A, Rietbergen JB, Denis LJ, Schroder FH, Prorok PC. Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. J Med Screen 1996;3: 97-104.
5. Stewart-Brown S, Farmer A. Screening could seriously damage your health [editorial]. BMJ 1997;314:533-4.
6. de Koning HJ, van Ineveld BM, de Haes JC, van Oortmarssen GJ, Klijn JG, van der Maas PJ. Advanced breast cancer and its prevention by screening. Br J Cancer 1992;65:950-5.
7. de Haes JC, de Koning HJ, van Oortmarssen GJ, van Agt HM, de Bruyn AE, van der Maas PJ. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 1991;49:538-44.
8. Schroder FH, Damhuis RA, Kirkels WJ, de Koning HJ, Kranse R, Nijs HG, et al. European randomized study of screening for prostate cancer - the Rotterdam pilot studies. Int J Cancer 1996;65:145-51.
9. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide. Boston: New England Medical Center, The Health Institute, 1993.
10. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental component summary measures - a users' manual. Boston: New England Medical Center, The Health Institute, 1994.
11. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison ot methods for the scoring and statistical analysis of SF-36 Health Profile and Summary measures: summary of results from the Medical Outcomes Study. Med Care 1995;33(4 Suppl):AS264-79.
12. Aaronson NK, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992;1:349-51.
13. Brooks RG, EuroQol Group. EuroQol: the current state of play. Health Policy 1996;37: 53-72.
14. EuroQol Group. EQ-5D user guide. Rotterdam, The Netherlands: EuroQol Business Management, 1996.
15. van der Ploeg HM, Defares PB, Spielberger CD, editors. Manual of the state-trait anxiety inventory (Handleiding bij de zelfbeoordelingsvragenlijst) (in Dutch). Leiden, The Netherlands: Swets & Zeitlinger, 1980.
16. van der Ploeg HM. Validation of the state-trait anxiety inventory (Validatie van de zelfbeoordelingsvragenlijst) (in Dutch). Ned T Psychol 1980;35:243-9.
17. Spielberger CD, Gorschuch RL, Lushene RE, editors. STAI manual for the state-trait anxiety inventory. Palo Alto (CA): Consulting Psychologists Press, 1970.
18. Rietbergen JB, Kruger AE, Kranse R, Schroder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875-80.
19. Sutton S, Saidi G, Bickler G, Hunter H. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 1995;49:413-8.
20. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-67.
21. Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of screening mammography. J Med Screen 1994;1:7-12.